AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimirab M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Unishine Health Care

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimirab M 1mg/500mg Tablet SR

Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headache, and trembling—and how to manage them. Consistent meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests for blood cell counts and liver function, will be recommended by your doctor.

Uses of Glimirab M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimirab M 1mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimirab M 1mg/500mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.

Common Side effects of Glimirab M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimirab M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimirab M 1mg/500mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.

How Glimirab M 1mg/500mg Tablet SR works:

Glimirab M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreased hepatic glucose production, reduced intestinal glucose uptake, and enhanced insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimirab M 1mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimirab M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimirab M tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from operating a vehicle if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimirab M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glimirab M 1mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, Glimirab M 1mg/500mg SR tablets require careful administration. Dosage modification of Glimirab M 1mg/500mg SR tablets may be necessary. Physician consultation is advised. In patients experiencing mild to moderate liver disease, Glimirab M 1mg/500mg SR tablets are typically initiated at a low dosage; however, their use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimirab M 1mg/500mg Tablet SR :

Should you forget to take a Glimirab M 1mg/500mg SR tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimirab M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimirab M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimirab M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimirab M 1mg/500mg Tablet SR and seek immediate medical attention.
Glimirab M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimirab M 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Glimirab M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimirab M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimirab M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimirab M 1mg/500mg Tabl...
41
MRP 48
14% off